Patents Assigned to Protease Sciences, INC
  • Cosmetic compositions containing serine protease inhibitors
    Patent number: 6294181
    Abstract: Cosmetic compositions and methods are provided for revitalizing the skin especially where it is placed in an environment that can cause injury to the skin. The compositions contain an effective amount of a serine protease inhibitor to reduce damage to the skin resulting from exposure to the sun.
    Type: Grant
    Filed: July 27, 2000
    Date of Patent: September 25, 2001
    Assignee: Protease Sciences, INC
    Inventor: John Lezdey
  • Cosmetic compositions containing human type serine protease inhibitors for revitalizing the skin
    Patent number: 6096327
    Abstract: Cosmetic compositions and methods are provided for revitalizing the skin especially where it is placed in an environment which can cause injury to the skin. The compositions contain an effective amount of a protease inhibitor to provide a prophylactic or repairing effect.
    Type: Grant
    Filed: November 5, 1998
    Date of Patent: August 1, 2000
    Assignee: Protease Sciences Inc.
    Inventors: John Lezdey, Allan Wachter
  • Dermatological and cosmetic compositions containing marama bean extract
    Patent number: 5869063
    Abstract: Compositions and methods are provided for treating the skin especially where it is placed in an environment which can cause injury or inflammation to the skin. The compositions contain an effective amount of the extract from marama beans.
    Type: Grant
    Filed: June 29, 1998
    Date of Patent: February 9, 1999
    Assignee: Protease Sciences, Inc.
    Inventors: John Lezdey, Allan Wachter
  • Treatment of pulmonary disease with protease inhibitors
    Patent number: 5780440
    Abstract: The invention relates to methods and compositions for the prevention or treatment of patients suffering from respiratory distress syndrome and/or sepsis syndrome by administering directly into the lungs small or nicrocrystalline particles or droplets of at least one protease inhibitor alone or with an oxygen metabolite scavenger. The method can also include the treatment in combination with the monitoring of the urine desmosine level of the patients and the use of DNase.
    Type: Grant
    Filed: October 11, 1996
    Date of Patent: July 14, 1998
    Assignee: Protease Sciences Inc.
    Inventors: John Lezdey, Allan Wachter, Barry Starcher